CBA Florida Inc. (fka CBAI)

[Pick _M_Low]

News for 'CBAI' - (Cord Blood America, Inc. to Evaluate Possible Strategic Alternatives)


LAS VEGAS, Oct. 12, 2011 /PRNewswire via COMTEX/ -- Cord Blood America, Inc.
(www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood
stem cell preservation company focused on bringing the life saving potential of
stem cells to families nationwide and internationally, today announced that its
Board of Directors will conduct a process to explore and evaluate strategic
alternatives for Cord Blood America to enhance shareholder value.

Cord Blood America has not set a timetable for completion of the evaluation
process or made a decision to pursue any particular transaction or other
alternative, and there can be no assurance that any transaction or other
alternative will be pursued or completed.

Cord Blood America does not intend to comment further regarding the evaluation
of possible strategic alternatives, unless a specific transaction or process is
concluded, or it otherwise deems further disclosure is appropriate or required.

About Cord Blood America

Cord Blood America is the parent company of CorCell, Companies, Inc., which
facilitates umbilical cord blood stem cell preservation for expectant parents
and their children. Its mission is to be the most respected stem cell
preservation company in the industry. Collected through a safe and non-invasive
process, cord blood stem cells offer a powerful and potentially life-saving
resource for treating a growing number of ailments, including cancer, leukemia,
blood, and immune disorders. To find out more about Cord Blood America, Inc.,
visit our website at http://www.corcell.com/. For investor information, visit
http://www.cordblood-america.com/.

CONTACT: Paul KnopickE & E Communications(949)
[e-mail]

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which
are made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. We use words such as "anticipate," "believe,"
"expect,'' "future," "intend," "plan," and similar expressions to identify
forward-looking statements. These statements including those related to the
growth of the industry, new stem cell treatments, and the Cord Blood America's
performance, are only predictions and are subject to certain risks,
uncertainties and assumptions. Additional risks are identified and described in
the Company's public filings with the Securities and Exchange Commission.
Statements made herein are as of the date of this press release and should not
be relied upon as of any subsequent date. The Company's past performance is not
necessarily indicative of its future performance. The Company does not
undertake, and the Company specifically disclaims any obligation to update any
forward-looking statements to reflect occurrences, developments, events, or
circumstances after the date of such statement.

SOURCE Cord Blood America, Inc.



www.prnewswire.com


Copyright (C) 2011 PR Newswire. All rights reserved

-0-




KEYWORD: Nevada

INDUSTRY KEYWORD: OTC

&nb sp; HEA

MTC

MEQ

SUBJECT CODE: PDT